Oxmax RSSAuthorisedThis medicine is authorised for use in the European UnionHemoglobin betafumaril (bovine)MedicineVeterinaryAuthorised
Page contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on OxmaxOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. Product details Name of medicine Oxmax Active substance Hemoglobin betafumaril (bovine) International non-proprietary name (INN) or common name Hemoglobin betafumaril (bovine) Pharmacotherapeutic group Blood substitutes and plasma protein fractions Authorisation details EMA product number EMEA/V/C/005132 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for OxmaxAdoptedReference Number: EMA/CVMP/374571/2023 English (EN) (123.31 KB - PDF)First published: 08/09/2023ViewNews on OxmaxMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 202308/09/2023This page was last updated on 23/05/2024Share this page